Russian government eyes tightening registration for new drugs

The Russian government is considering providing additional legal and legislative support for domestic drugmakers in their patent disputes with foreign competitors, according to recent statements by some senior officials from the Russian Ministry of Health and some leading local drugmakers.

As Russian producers said, many of them have been able to complete the development of their own generics of some original foreign drugs, reports The Pharma Letter’s local correspondent.

In the majority of cases, their launch in the market takes place much earlier than submitting patent applications by foreign producers. However, despite this, the Russian arbitration courts continue to take the side of original manufacturers during their judicial proceedings with Russian producers of generics.